TAILIEUCHUNG - Calprotectin in cystic fibrosis

There is increasing evidence that intestinal inflammation plays a major role in gastrointestinal symptoms in cystic fibrosis (CF). Fecal calprotectin is a marker that is elevated in several gastrointestinal inflammatory diseases, but little is known about its value in CF. | Rumman et al. BMC Pediatrics 2014 14 133 http 1471-2431 14 133 BMC Pediatrics RESEARCH ARTICLE Open Access Calprotectin in Cystic Fibrosis Nisreen Rumman1 3 Mutaz Sultan2 3 Khalil El-Chammas2 5 Vi Goh2 4 Nita Salzman2 Diana Quintero1 and Steven Werlin2 Abstract Background There is increasing evidence that intestinal inflammation plays a major role in gastrointestinal symptoms in cystic fibrosis CF . Fecal calprotectin is a marker that is elevated in several gastrointestinal inflammatory diseases but little is known about its value in CF. We aimed to look for associations of elevated fecal calprotectin among CF patients and whether its level correlates with the clinical manifestations of CF. Methods A single stool specimen was collected from 62 patients with CF. Fecal calprotectin was measured using the commercially available ELISA kits PhiCal test . Clinical data were collected from patients records and CF registry. Results There were no significant differences between CF patients with normal and abnormal fecal calprotectin levels. However patients who were not receiving inhaled antibiotics had higher fecal calprotectin levels than those who were. Conclusion Elevated fecal calprotectin may not accurately predict intestinal inflammation in CF. However the fact that it was elevated in both pancreatic sufficient and insufficient groups supports the concept of cystic fibrosis enteropathy regardless of the pancreatic status. Background Cystic fibrosis CF is the most common cause of pancreatic insufficiency PI in children. Between 85 - 90 of CF patients have PI and malabsorption. These patients are typically treated with pancreatic enzyme replacement therapy PERT . However CF patients with pancreatic sufficiency PS and patients with PI who receive adequate PERT may have persistent abdominal symptoms. It has been suggested that other poorly understood non pancreatic confounding factors are likely contributors 1 . There is no specific noninvasive test

TỪ KHÓA LIÊN QUAN
TAILIEUCHUNG - Chia sẻ tài liệu không giới hạn
Địa chỉ : 444 Hoang Hoa Tham, Hanoi, Viet Nam
Website : tailieuchung.com
Email : tailieuchung20@gmail.com
Tailieuchung.com là thư viện tài liệu trực tuyến, nơi chia sẽ trao đổi hàng triệu tài liệu như luận văn đồ án, sách, giáo trình, đề thi.
Chúng tôi không chịu trách nhiệm liên quan đến các vấn đề bản quyền nội dung tài liệu được thành viên tự nguyện đăng tải lên, nếu phát hiện thấy tài liệu xấu hoặc tài liệu có bản quyền xin hãy email cho chúng tôi.
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.